Company Search:
Advanced Search
Sponsored Links
Lineage Cell Therapeutics Inc Company Snapshot
Lineage Cell Therapeutics Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Lineage Cell Therapeutics Inc with three other companies in this sector in the United States: Fate Therapeutics Inc (2018 sales of $4.74 million of which 100% was Biopharmaceuticals), Erytech Pharma SA ($5.24 million of which 100% was Pharmacy), and Organovo Holdings Incorporated ($4.60 million of which 100% was Developing and Commercializing Human Tis).

Sales Analysis. Lineage Cell Therapeutics Inc reported sales of $4.99 million for the year ending December of 2018. This represents an increase of 44.2% versus 2017, when the company's sales were $3.46 million. Despite this increase, sales are still well below the level achieved in 2016, when Lineage Cell Therapeutics Inc reported sales of $5.92 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Lineage Cell Therapeutics Inc
  Stock Performance Chart for Lineage Cell Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): .78
(Figures in U.S. Dollars)
1 Week -13.2%   13 Weeks -1.9%  
4 Weeks -15.2%   52 Weeks -41.7%  
Lineage Cell Therapeutics Inc Key Data:
  Ticker: LCTX Country: United States
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 4,988,000
(Year Ending Jan 2019).
Employees: 79
  Currency: U.S. Dollars Market Cap: 116,985,990
  Fiscal Yr Ends: December Shares Outstanding: 149,790,000
  Share Type: Common Closely Held Shares: 8,685,393
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.